Paediatric oxygen therapy at home in India is a smaller clinical population than adult LTOT but carries a higher complication-rate ceiling when things go wrong. Flow rates scale with age and weight, humidity matters in ways adult prescriptions can get away with ignoring, equipment sizing is fundamentally different from adult stationary concentrators, and the family is being asked to assume ICU-adjacent responsibility at home. This article walks through the paediatric indications, the age-scaled prescribing, and the equipment choices that work — and fail — for infants and children in the Indian home setting.
The audience is the neonatologist, paediatric pulmonologist, and home-care provider handing over equipment after a NICU or PICU discharge, and the family trying to understand why a pulse-dose portable is not safe for their two-year-old.
Paediatric indications for chronic home oxygen
The common indications in Indian paediatric practice:
Bronchopulmonary dysplasia (BPD) / chronic lung disease of prematurity (CLD). Infants born at 24–28 weeks gestation who required prolonged ventilation or CPAP in NICU and remain oxygen-dependent at 36 weeks corrected gestational age. BPD is a disease of healing — most infants wean off oxygen by 12–24 months corrected age. Indian NICUs at tertiary centres (AIIMS, CMC Vellore, KEM, Sir Ganga Ram, Narayana Health) have increasing post-NICU oxygen discharge volumes as neonatal survival at lower gestational ages improves.
Congenital heart disease. Ductal-dependent lesions pre- and post-surgery, Eisenmenger physiology in unrepaired septal defects, residual pulmonary vascular disease after shunt ligation. Oxygen here is both therapeutic (reducing pulmonary vascular resistance in select cases) and symptomatic.
Pulmonary hypertension of infancy. Persistent pulmonary hypertension of the newborn extending into home setting; idiopathic PAH in older children.
Cystic fibrosis. Less common in Indian populations than in European cohorts but not absent. Advancing CF lung disease mirrors adult ILD trajectory for oxygen need.
Neuromuscular disease. Spinal muscular atrophy, Duchenne muscular dystrophy, congenital myopathies with respiratory muscle weakness. Oxygen here is usually part of a broader NIV/BiPAP ventilation package.
Interstitial lung disease of childhood (chILD). Rare but present — surfactant protein deficiencies, neuroendocrine cell hyperplasia of infancy, ABCA3 mutations.
Sickle cell disease with chronic hypoxaemia. Tribal-belt Indian populations (central, eastern) have meaningful sickle cell prevalence.
Post-infectious fibrosis — post-measles, post-TB, post-severe COVID. A specific Indian subgroup of paediatric post-COVID oxygen dependence emerged in 2021–22.
Saturation targets — not the adult 88–92%
Paediatric saturation targets differ from adult targets and differ across age subgroups.
Premature neonates and infants with BPD. Target SpO₂ 90–95% is the mainstream recommendation. The evidence in this group is unusual — the SUPPORT, BOOST-II, and COT trials examined lower-range (85–89%) vs higher-range (91–95%) targets in preterm infants and found higher-range had better survival but more retinopathy of prematurity risk. Post-NICU discharge targets settled around 92–95% for most BPD infants, with some centres using 93–95% as standard.
Term infants and young children with cyanotic heart disease. Baseline saturation is lower than normal; targets depend on the specific lesion and stage of palliation. A single-ventricle patient post-Glenn palliation may have baseline SpO₂ 75–85% as normal; home oxygen targets are set by the cardiology team, not by generic LTOT thresholds.
Older children with chronic lung disease. Target SpO₂ ≥ 92%, similar to adult LTOT targets but with exertional assessment relevant given activity levels.
The critical nuance: the adult 88–92% target does not apply to most paediatric patients. Paediatric oxygen prescription should always have an age- and diagnosis-specific target documented on the prescription, and home pulse oximeters should be set with appropriately narrow alarm limits.
Flow-rate scaling
Paediatric oxygen flow is a much smaller range than adult flow, and it requires a flowmeter with fine resolution.
Neonates (0–1 month). Flows of 25 mL/min to 500 mL/min (0.025 to 0.5 LPM) are typical for BPD infants on home oxygen. Adult flowmeters calibrated in 0.5 LPM increments cannot deliver these flows accurately. A paediatric flowmeter — the Precision Medical 1 LPM or equivalent, with 50 mL/min graduations — is essential.
Infants (1–12 months). Flows of 0.25–1 LPM are typical, scaling up toward 1–2 LPM for larger infants or more severe disease.
Toddlers and preschool (1–6 years). 0.5–2 LPM typical, up to 3–4 LPM for advancing disease.
School-age and adolescent (6–18 years). Flows approaching adult scaling — 1–5 LPM for most indications, occasionally higher in end-stage CF or chILD.
The adult default 2 LPM cannula flow is too much oxygen for a 2 kg neonate. Over-oxygenation in this group risks oxygen-radical injury to the developing retina (ROP) and, in certain congenital heart lesions, increases pulmonary blood flow at the expense of systemic perfusion. Paediatric oxygen is titrated carefully to target saturation, not delivered at a default flow.
Humidification — not optional in paediatrics
Adult oxygen at 1–2 LPM can often be delivered without humidification without clinical problems. Paediatric oxygen — particularly neonatal and infant — cannot.
The paediatric airway is smaller, surface-area-to-volume ratios are different, and dry gas causes mucosal injury, crusting, and airway obstruction that an adult can compensate for but a neonate cannot. Tracheitis, mucus plugging, and cannula occlusion are all described in infants on dry home oxygen.
The humidification requirements:
Bubble humidifier. The basic ₹300–800 water-column humidifier on the concentrator output is adequate for most paediatric flows up to 2 LPM. Distilled or sterile water, changed daily in coastal humidity or every 3 days otherwise. The humidifier bottle should be below the patient level to prevent aspiration of bottle water through the tubing.
Heated humidifier. At flows of 2+ LPM or when tolerated poorly on cold humidity, a heated humidifier with integrated thermistor (similar to CPAP humidifier principles but flow-rate-sized for concentrator output) provides higher absolute humidity and mucosal comfort.
Heated-wire circuit. For high-flow paediatric oxygen (high-flow nasal cannula systems like Fisher & Paykel Optiflow Junior, Airvo 2 Junior), heated-wire tubing prevents rain-out of condensation. These systems are NICU-step-down-discharge equipment and are not common in Indian home settings yet.
Humidity zones matter. A BPD infant in coastal Chennai or Mumbai can often get by with bubble humidification through the summer months; the same infant in Delhi winter (low ambient humidity, furnace-dried indoor air) may need heated humidification to avoid mucosal drying.
Interface selection — cannula sizing matters
Adult nasal cannulas are sized around 3–4 mm outer-diameter prongs. Paediatric cannulas require smaller prong diameter and shorter lengths.
Neonatal cannula (0–5 kg) — smallest prong, soft silicone, secured with tape across the cheeks.
Infant cannula (5–15 kg) — slightly larger, still soft, tape or head-strap.
Paediatric cannula (15–40 kg) — intermediate, may use ear-loop style similar to adult cannulas.
Adult cannula — from ~40 kg and up.
Using an adult cannula on an infant causes pressure points, nasal mucosal injury, and cannula dislodgement. Every paediatric home oxygen setup in India should include age-appropriate cannulas — the dealer handing over a concentrator with only adult cannulas in the bag is not serving the paediatric patient adequately.
Mask interfaces in paediatrics — simple mask, non-rebreather — are available in paediatric sizes and should be size-matched. A paediatric non-rebreather fits over the mouth and nose without covering the eyes; the adult mask on a small child both fits poorly and generates claustrophobia.
Equipment selection — why pulse-dose portables are rarely paediatric
The portable pulse-dose concentrator — Inogen One G4/G5, Philips SimplyGo Mini, CAIRE FreeStyle Comfort — is popular for adult ambulation. It is usually the wrong device for a paediatric patient.
First, the bolus trigger mechanism depends on a well-defined inspiratory effort. Infants and young children have respiratory patterns (shallow, fast, mouth-breathing during sleep) that under-trigger pulse-dose units. The saturation falls without the device alarming.
Second, the numbered settings (1–5 or 1–6) on pulse-dose devices do not correspond to flow rates but to approximate bolus volumes calibrated on adult breathing patterns. A “setting 2” on an Inogen is not 2 LPM continuous — it is a fixed bolus per detected breath, and the effective minute-oxygen is breath-rate-dependent. For a paediatric patient, the relationship is unreliable.
Third, the minimum flow on many portable units is too high for a neonate who may need 50–200 mL/min.
The correct equipment for most paediatric home oxygen:
Stationary concentrator with paediatric flowmeter. A 5 LPM concentrator (Oxymed 5L, Philips EverFlo, Nidek Mark 5, Invacare PlatinumMobile, Home Medix HM-KV) fitted with a paediatric flowmeter that reads down to 100 mL/min. Stationary, high reliability, continuous flow.
Cylinder-based ambulation. For outings and emergencies, an E-size or D-size cylinder with paediatric regulator. Transit from concentrator to cylinder is the common failure point — coordinate with the home-care dealer on cylinder supply logistics.
Liquid oxygen — rarely available in Indian home settings, occasionally in tertiary-centre BPD step-down programmes.
Parental training — the non-negotiable step
Paediatric home oxygen is fundamentally different from adult LTOT in one respect: the patient cannot self-monitor, self-titrate, or self-report. The parent or carer becomes the respiratory therapist.
The training the family needs before discharge:
- How to measure SpO₂ on their child with a paediatric-sized pulse oximeter. Wrist-wrap or toe sensors for infants; fingertip for older children. Clinical-grade oximeters (Masimo, Nonin) read more reliably on small patients than consumer devices.
- What the target range is and what to do if saturation drops below it — titrate up by a documented increment, check the equipment, call the clinic, go to the ED.
- What to do if the concentrator stops. Many families in Indian tier-2 cities have power cuts; the backup plan is cylinder-based. The cylinder must be physically at home with a functional regulator and the family must know how to use it.
- Humidifier fill and change routine.
- Cannula changes, hygiene, skin-breakdown inspection.
- What an alarm means on the concentrator and what to do with it.
- When to seek emergency care versus call the clinic.
Indian NICU step-down programmes with mature oxygen-discharge pathways (AIIMS, PGI Chandigarh, CMC Vellore) typically train the family over multiple sessions before discharge. Dealer-only handover without structured parental training is a patient-safety issue.
CDSCO and regulatory status
Paediatric medical devices in India fall under CDSCO regulation. A device marketed for paediatric use should carry documentation of paediatric-range calibration and appropriate paediatric accessories. In practice, most concentrators sold in India are not specifically marketed as paediatric devices; the concentrator is adult-range with a paediatric flowmeter fitted. The fitting dealer is responsible for the paediatric appropriateness of the complete setup. Ask the dealer to show the paediatric flowmeter spec sheet.
Oximeters marketed for paediatric use should carry paediatric-range calibration. Many Indian-market consumer oximeters carry “paediatric” labels without demonstrable paediatric calibration data. For BPD and cardiac-lesion home monitoring, a clinical-grade oximeter (Masimo Rad-5, Nonin Onyx 9560) is worth the price premium.
Cost and NICU-step-down economics
A 5 LPM concentrator with paediatric flowmeter and humidifier, in India, 2026: ₹45,000–80,000 purchase, or ₹4,000–8,000/month rental. For a BPD infant who is likely to wean off oxygen within 6–18 months, rental is almost always the right choice economically. Purchase makes sense for chronic indications (chILD, neuromuscular disease) with longer-horizon use.
Cylinder supply costs vary regionally — metro tier-1 cities ₹400–700 per refill for a D-size cylinder, tier-2/3 cities sometimes more due to supply-chain distances.
A quality paediatric pulse oximeter: ₹8,000–25,000 for a clinical-grade unit. ₹500–2,500 for a consumer unit — fine for general trending, not adequate for a BPD infant making prescription decisions.
Clinical takeaway
Paediatric oxygen therapy at home demands age-scaled flow (neonates at 25–500 mL/min, not LPM), diagnosis-specific saturation targets (not the adult 88–92%), a stationary concentrator with paediatric flowmeter (not an adult flowmeter and not a pulse-dose portable), appropriate humidification, age-sized cannulas, and substantive parental training before discharge. BPD is usually time-limited; most infants wean within 12–24 months. Liquid oxygen and heated-wire high-flow systems are NICU-step-down tools that have not yet penetrated Indian home care broadly.
Consult your paediatric pulmonologist or neonatologist before changing oxygen therapy; paediatric titration decisions are not transferable from adult LTOT rules and require diagnosis-specific judgement.